Windtree Therapeutics, Inc. (WINT)
NASDAQ: WINT · Real-Time Price · USD
0.700
-0.021 (-2.91%)
Nov 4, 2024, 4:00 PM EST - Market closed
Windtree Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | - | - | - | - | - | 0.2 | Upgrade
|
| Revenue Growth (YoY) | - | - | - | - | - | -88.93% | Upgrade
|
| Cost of Revenue | - | - | - | - | - | 12.69 | Upgrade
|
| Gross Profit | - | - | - | - | - | -12.49 | Upgrade
|
| Selling, General & Admin | 7.73 | 8.7 | 10.79 | 14.47 | 14.04 | 12.4 | Upgrade
|
| Research & Development | 17.08 | 8.14 | 10.7 | 17.79 | 15.37 | - | Upgrade
|
| Operating Expenses | 24.81 | 16.84 | 21.49 | 32.26 | 29.42 | 12.4 | Upgrade
|
| Operating Income | -24.81 | -16.84 | -21.49 | -32.26 | -29.42 | -24.89 | Upgrade
|
| Interest Expense | -0.15 | -0.05 | -0.05 | -0.11 | -0.13 | -0.5 | Upgrade
|
| Interest & Investment Income | 0.22 | 0.33 | 0.11 | 0.09 | 0.12 | 0.15 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.2 | - | 0.7 | -0.3 | -1.2 | -0.5 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.36 | 0.03 | 0 | -0.02 | -1.05 | 0.05 | Upgrade
|
| EBT Excluding Unusual Items | -24.89 | -16.53 | -20.73 | -32.6 | -31.67 | -25.68 | Upgrade
|
| Merger & Restructuring Charges | -0.7 | -0.7 | - | - | - | - | Upgrade
|
| Impairment of Goodwill | - | -3.06 | -12.62 | - | - | - | Upgrade
|
| Asset Writedown | - | - | -7.22 | -45.02 | - | - | Upgrade
|
| Other Unusual Items | 14.52 | - | - | - | -0.9 | -1.79 | Upgrade
|
| Pretax Income | -11.07 | -20.29 | -40.58 | -77.62 | -32.57 | -27.48 | Upgrade
|
| Income Tax Expense | 0.31 | - | -1.37 | -9.99 | - | - | Upgrade
|
| Net Income | -11.38 | -20.29 | -39.21 | -67.64 | -32.57 | -27.48 | Upgrade
|
| Net Income to Common | -11.38 | -20.29 | -39.21 | -67.64 | -32.57 | -27.48 | Upgrade
|
| Shares Outstanding (Basic) | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Change (YoY) | 368.05% | 515.24% | 27.27% | 58.11% | 43.25% | - | Upgrade
|
| EPS (Basic) | -27.95 | -94.23 | -1120.23 | -2459.49 | -1872.36 | -2262.81 | Upgrade
|
| EPS (Diluted) | -27.95 | -94.23 | -1120.23 | -2459.49 | -1872.36 | -2262.81 | Upgrade
|
| Free Cash Flow | -12.72 | -13.45 | -19.47 | -23.94 | -25.61 | -24.85 | Upgrade
|
| Free Cash Flow Per Share | -31.23 | -62.47 | -556.14 | -870.65 | -1472.20 | -2046.94 | Upgrade
|
| Operating Margin | - | - | - | - | - | -12572.22% | Upgrade
|
| Profit Margin | - | - | - | - | - | -13876.26% | Upgrade
|
| Free Cash Flow Margin | - | - | - | - | - | -12552.53% | Upgrade
|
| EBITDA | -24.67 | -16.76 | -21.36 | -32.07 | -29.25 | -24.7 | Upgrade
|
| D&A For EBITDA | 0.14 | 0.08 | 0.13 | 0.19 | 0.17 | 0.2 | Upgrade
|
| EBIT | -24.81 | -16.84 | -21.49 | -32.26 | -29.42 | -24.89 | Upgrade
|
| Revenue as Reported | - | - | - | - | - | 0.2 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.